跳转至内容
Merck
CN
  • Reversible acetylation regulates salt-inducible kinase (SIK2) and its function in autophagy.

Reversible acetylation regulates salt-inducible kinase (SIK2) and its function in autophagy.

The Journal of biological chemistry (2013-01-17)
Fu-Chia Yang, Bertrand Chin-Ming Tan, Wei-Hao Chen, Ya-Huei Lin, Jing-Yi Huang, Hsin-Yun Chang, Hui-Yu Sun, Pang-Hung Hsu, Gunn-Guang Liou, James Shen, Ching-Jin Chang, Chau-Chung Han, Ming-Daw Tsai, Sheng-Chung Lee
摘要

Salt-inducible kinase 2 (SIK2) is a serine/threonine protein kinase belonging to the AMP-activated protein kinase (AMPK) family. SIK2 has been shown to function in the insulin-signaling pathway during adipocyte differentiation and to modulate CREB-mediated gene expression in response to hormones and nutrients. However, molecular mechanisms underlying the regulation of SIK2 kinase activity remains largely elusive. Here we report a dynamic, post-translational regulation of its kinase activity that is coordinated by an acetylation-deacetylation switch, p300/CBP-mediated Lys-53 acetylation inhibits SIK2 kinase activity, whereas HDAC6-mediated deacetylation restores the activity. Interestingly, overexpression of acetylation-mimetic mutant of SIK2 (SIK2-K53Q), but not the nonacetylatable K53R variant, resulted in accumulation of autophagosomes. Further consistent with a role in autophagy, knockdown of SIK2 abrogated autophagosome and lysosome fusion. Consequently, SIK2 and its kinase activity are indispensable for the removal of TDP-43Δ inclusion bodies. Our findings uncover SIK2 as a critical determinant in autophagy progression and further suggest a mechanism in which the interplay among kinase and deacetylase activities contributes to cellular protein pool homeostasis.